The Klinique Medical Clinic PCL (BKK:KLINIQ)
24.90
-0.10 (-0.40%)
Jun 23, 2026, 12:29 PM ICT
BKK:KLINIQ Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, BKK:KLINIQ stock has a consensus rating of "Strong Buy" and an average price target of ฿30.50. The average 1-year stock price forecast is 22.49% higher than the current stock price, while the lowest is ฿28.00 (+12.45%) and the highest is ฿33.00 (+32.53%).
Price Target: ฿30.50 (+22.49%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BKK:KLINIQ stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Financial Forecast
Revenue This Year
3.98B
from 3.56B
Increased by 11.83%
Revenue Next Year
4.38B
from 3.98B
Increased by 10.17%
EPS This Year
1.77
from 1.65
Increased by 6.97%
EPS Next Year
1.97
from 1.77
Increased by 11.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.0B | ||
| Avg | 4.0B | ||
| Low | 3.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.0% | ||
| Avg | 11.8% | ||
| Low | 10.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.83 | ||
| Avg | 1.77 | ||
| Low | 1.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.9% | ||
| Avg | 7.0% | ||
| Low | 3.0% |